AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 108 filers reported holding AVROBIO INC in Q4 2020. The put-call ratio across all filers is 2.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $15,131 | -4.3% | 16,556 | 0.0% | 0.00% | – |
Q1 2023 | $15,811 | +36.4% | 16,556 | 0.0% | 0.00% | – |
Q4 2022 | $11,590 | +5.4% | 16,556 | -1.6% | 0.00% | – |
Q3 2022 | $11,000 | -38.9% | 16,832 | -9.9% | 0.00% | – |
Q2 2022 | $18,000 | -28.0% | 18,687 | 0.0% | 0.00% | – |
Q1 2022 | $25,000 | -65.3% | 18,687 | 0.0% | 0.00% | – |
Q4 2021 | $72,000 | -68.6% | 18,687 | +15.1% | 0.00% | – |
Q4 2020 | $229,000 | – | 16,229 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BML Capital Management, LLC | 4,001,627 | $6,162,506 | 5.66% |
Vazirani Asset Management LLC | 468,273 | $721,140 | 1.10% |
Atlas Venture Life Science Advisors, LLC | 4,541,381 | $6,993,727 | 1.08% |
Terrapin Asset Management, LLC | 558,787 | $860,532 | 0.98% |
TANG CAPITAL MANAGEMENT LLC | 3,512,686 | $5,409,536 | 0.76% |
Newtyn Management, LLC | 2,000,000 | $3,080,000 | 0.76% |
Aldebaran Capital, LLC | 470,130 | $724,000 | 0.74% |
Aisling Capital Management LP | 1,009,779 | $1,555,060 | 0.64% |
Western Standard LLC | 310,361 | $477,956 | 0.43% |
Affinity Asset Advisors, LLC | 500,000 | $770,000 | 0.22% |